Successful MDR-TB Treatment Without HIV Viral Suppression: A Missed Opportunity.

Keri GeigerAmita PatilChakra BudhathokiKelly E DooleyKelly LowensenNorbert NdjekaJaqueline NgozoJason E Farley

Published in: Journal of acquired immune deficiency syndromes (1999) (2023)

Increased pill burden and adverse treatment effects did not significantly affect HIV viral suppression, while switching ART to a protease inhibitor to accommodate bedaquiline or not changing ART while taking bedaquiline did, suggesting that PWH and MDR-TB may benefit from additional support if they must switch ART.

Keyphrases

antiretroviral therapy
hiv infected
multidrug resistant
hiv positive
human immunodeficiency virus
drug resistant
sars cov
hepatitis c virus
mycobacterium tuberculosis
risk factors
combination therapy
electronic health record
replacement therapy